The HCC Neuro-Oncology SPORE Developmental Research Program funds translational research projects in adult or pediatric gliomas with the goal of upgrading successful projects to full SPORE project status. Unlike the CEP (entry #2), the DRP targets established faculty and emphasizes bench-to-bedside or bedside-to-bench translational strategies.
Eligibility Criteria:
Applicants must:
- Be a faculty member at Harvard Medical School or Harvard School of Public Health at the rank of Instructor or higher
- Propose research focused on adult or pediatric gliomas with a clear translational (bench-to-bedside or bedside-to-bench) strategy
- Obtain a letter from their department chair agreeing to provide $25,000 in matching funds (direct + institutional indirect)
- Submit a Research Plan (≤3 pages) with Specific Aims, Background and Relevance to Gliomas, Preliminary Data, and Methods
Funding Details:
- Award amount: $25,000 (total) from the SPORE grant + $25,000 (direct) from the applicant’s department = $50,000 total support
- Duration: 1 year (September 1, 2026 – August 1, 2027)
- Number of awards: 2
- Indirect costs: Institutional/nonfederal indirect on the departmental match only
Deadline:
- LOI due: N/A (no LOI stage)
- Full application due: July 1, 2026
- Award notification: July 15, 2026; funding start: September 1, 2026
Where to go for further information: